Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Symphar Logo
Symphar CB Rank
739656
Heat Score
45
SymPhar provides pharmaceutical, medical, and nutritional products.
Acquired by
Farmak Logo
Farmak
Founded
obfuscation
Private Warszawa, Mazowieckie, Poland101-250 www.symphar.com/
Biotechnology
Consumer Goods
Health Care
Pharmaceutical
Overview

Symphar
Heat Score
45

Growth Score
pts
in past quarter
Heat Score 45
9 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Symphar

CB Rank
739656
SymPhar provides pharmaceutical, medical, and nutritional products.
Acquired by
Farmak Logo
Farmak
Founded
obfuscation
Private Warszawa, Mazowieckie, Poland101-250 www.symphar.com/
Biotechnology
Consumer Goods
Health Care
Pharmaceutical

Key People

Details

Operating Status Closed
Company Type For Profit
Founders  Simon Lucas
About the Company
SymPhar provides pharmaceutical, medical, and nutritional products.
Phone Number 48.22.822.93.06
Contact Email ewa.hechmann@symphar.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Dutilox
A prescription medication containing duloxetine used to treat depression, generalized anxiety disorder, and diabetic neuropathic pain in adults.
Symapamid®SR
A prolonged-release tablet containing indapamide used to treat essential (primary) hypertension.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

M&A Details

Symphar was acquired by Farmak on
obfuscation
. This deal was done in Cash.
Transaction Name 
Symphar acquired by Farmak Logo
Symphar acquired by Farmak
Acquired by 
Farmak Logo
Farmak
Announced Date 
obfuscation
Market Intelligence
People
View Profiles & Contacts
Headcount 101-250 Employee Profiles 1 Contacts 1

Employee Profiles

News

News and Press

News•Mar 28, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

124
226.32%
 in past month

IT Spend

$327KThis year, Symphar is projected to spend $327K on IT, according to Aberdeen.

Active Website Tech Count

4Symphar is actively using 4 technologies for its website, according to BuiltWith. These include DNSSEC, Facebook Sharer, and  Pinterest.
Sub-Organizations
Frequently Asked Questions

Where is Symphar's headquarters? Symphar is located in Warszawa, Mazowieckie, Poland.Who are Symphar's competitors? Alternatives and possible competitors to Symphar may include Amara, Kalceks, and  Tillomed.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(be4ac66 1)
|